1. Home
  2. ARTV vs FSI Comparison

ARTV vs FSI Comparison

Compare ARTV & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • FSI
  • Stock Information
  • Founded
  • ARTV 2019
  • FSI 1991
  • Country
  • ARTV United States
  • FSI Canada
  • Employees
  • ARTV N/A
  • FSI N/A
  • Industry
  • ARTV
  • FSI Recreational Games/Products/Toys
  • Sector
  • ARTV
  • FSI Consumer Discretionary
  • Exchange
  • ARTV NYSE
  • FSI Nasdaq
  • Market Cap
  • ARTV 50.7M
  • FSI 55.6M
  • IPO Year
  • ARTV 2024
  • FSI 1999
  • Fundamental
  • Price
  • ARTV $1.63
  • FSI $4.44
  • Analyst Decision
  • ARTV Strong Buy
  • FSI
  • Analyst Count
  • ARTV 8
  • FSI 0
  • Target Price
  • ARTV $18.14
  • FSI N/A
  • AVG Volume (30 Days)
  • ARTV 155.1K
  • FSI 17.9K
  • Earning Date
  • ARTV 05-08-2025
  • FSI 08-13-2025
  • Dividend Yield
  • ARTV N/A
  • FSI 2.24%
  • EPS Growth
  • ARTV N/A
  • FSI N/A
  • EPS
  • ARTV N/A
  • FSI 0.18
  • Revenue
  • ARTV N/A
  • FSI $36,483,680.00
  • Revenue This Year
  • ARTV N/A
  • FSI $21.91
  • Revenue Next Year
  • ARTV N/A
  • FSI $42.35
  • P/E Ratio
  • ARTV N/A
  • FSI $24.57
  • Revenue Growth
  • ARTV N/A
  • FSI N/A
  • 52 Week Low
  • ARTV $1.55
  • FSI $1.65
  • 52 Week High
  • ARTV $17.31
  • FSI $7.24
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • FSI 55.25
  • Support Level
  • ARTV N/A
  • FSI $4.21
  • Resistance Level
  • ARTV N/A
  • FSI $4.42
  • Average True Range (ATR)
  • ARTV 0.00
  • FSI 0.16
  • MACD
  • ARTV 0.00
  • FSI -0.00
  • Stochastic Oscillator
  • ARTV 0.00
  • FSI 62.16

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

Share on Social Networks: